Cover Image

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis

Immune-checkpoint inhibitors (ICIs) have widened the therapeutic scenario of different cancer types. Phase I/II trials have been designed to evaluate the role of ICIs both as single agents and in combination in neuroendocrine neoplasms (NENs), but as yet no randomized controlled phase III trials hav...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alberto Bongiovanni (Author), Brigida Anna Maiorano (Author), Irene Azzali (Author), Chiara Liverani (Author), Martine Bocchini (Author), Valentina Fausti (Author), Giandomenico Di Menna (Author), Ilaria Grassi (Author), Maddalena Sansovini (Author), Nada Riva (Author), Toni Ibrahim (Author)
Format:	Book
Published:	MDPI AG, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
by: Jingci Chen, et al.
Published: (2021)

Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
Published: (2021)

Mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder: case report and literature review
by: Xu Ren, et al.
Published: (2022)

Disseminated neuroendocrine neoplasm with undetected primary tumor
by: Frederico Becker Ribeiro, et al.
Published: (2012)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
by: Melpomeni Fani, et al.
Published: (2017)

Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
by: Kenta Kawasaki, et al.
Published: (2018)

A Case of Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm Composed With Adenoma and Neuroendocrine Tumor
by: Kwon-Eui Hong, et al.
Published: (2023)

A Case Report: Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Aggressive Neuroendocrine Component
by: Quang Duy Pham, et al.
Published: (2017)

Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
by: José Manuel Lopes
Published: (2017)

Mixed neuroendocrine/Non-neuroendocrine neoplasm (MiNEN) of gastrointestinal lineage arising in an ovarian mature cystic teratoma
by: Sandhyarani Dasaraju, et al.
Published: (2022)

Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report
by: Yasuko Fujita, et al.
Published: (2019)

Comparison of insulinoma-associated protein 1 (INSM1) with traditional neuroendocrine markers in gastrointestinal and pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs)
by: Rui Gao, et al.
Published: (2024)

Correlation between expression of immunohistochemical markers and morphology in lung neuroendocrine neoplasms
by: Halyna Chytaieva, et al.
Published: (2022)

Usefulness of micro forceps biopsy for cystic degenerated pancreatic neuroendocrine neoplasm
by: Takuya Doi, et al.
Published: (2024)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020)

High-grade mixed neuroendocrine non-neuroendocrine neoplasm of the gastroesophageal junction: A rare case report and review of literature
by: Mohamed Sulaiman, et al.
Published: (2022)

A pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) (NET and undifferentiated carcinoma of the pancreas with osteoclast-like giant cells) with metastatic neuroendocrine component to the liver
by: Guofeng Gao, et al.
Published: (2021)

Epidemiological characteristics of neuroendocrine neoplasms in Beijing: a population-based retrospective study
by: Yujia Chi, et al.
Published: (2024)

Review of Checkpoint Inhibitor Immunotherapy in Neuroendocrine Tumor of Prostate and Our Experience in 2 Cases
by: Akriti Pokhrel MD, et al.
Published: (2022)

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
by: Brigida Anna Maiorano, et al.
Published: (2023)

Efficacy of immune checkpoint inhibitors in different types of melanoma
by: Ernesto Rossi, et al.
Published: (2021)

IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms
by: Ewelina Motylewska, et al.
Published: (2020)

(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
by: Irina Velikyan
Published: (2020)

Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm
by: Brooke Mullen, et al.
Published: (2024)

Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
by: Massimo Milione, et al.
Published: (2019)

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
by: Francesca Spada, et al.
Published: (2021)

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma
by: Melissa Bersanelli, et al.
Published: (2023)

Niraparib and Advanced Ovarian Cancer: A Beacon in the Non-BRCA Mutated Setting
by: Mauro Francesco Pio Maiorano, et al.
Published: (2023)

Neuroendocrine Tumor
Published: (2012)

Canonical analysis of neuroendocrine-metabolic and neuroendocrine-immune relationships at female rats
by: Oksana Mel'nyk, et al.
Published: (2021)

Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary
by: Merijn CF Mulders, et al.
Published: (2024)

Endocrine and Neuroendocrine Cancers
Published: (2023)

Neuroendocrine Cervical Carcinoma
by: Yulian Prastisia, et al.
Published: (2023)

Neuroendocrine tumors of the vagina
by: S. O. Nikogosyan, et al.
Published: (2015)

Neuroendocrine Tumors in Pediatrics
by: Zainab Azam Farooqui, et al.
Published: (2019)

Neuroendocrine breast carcinoma
by: Laura Pratas Guerra, et al.
Published: (2024)

An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020)

Neoplasm
Published: (2018)

Glucose Metabolism Modification Induced by Radioligand Therapy with [<sup>177</sup>Lu]Lu/[<sup>90</sup>Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial
by: Luca Urso, et al.
Published: (2022)

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
by: Maria Maddalena Nicoletti, et al.
Published: (2023)